BIO.B (Bio-Rad Laboratories) Additional Paid-In Capital : $448 Mil(As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories Additional Paid-In Capital?

Bio-Rad Laboratories's quarterly additional paid-in capital increased from Mar. 2024 ($463 Mil) to Jun. 2024 ($475 Mil) but then stayed the same from Jun. 2024 ($475 Mil) to Sep. 2024 ($448 Mil).

Bio-Rad Laboratories's annual additional paid-in capital increased from Dec. 2021 ($442 Mil) to Dec. 2022 ($447 Mil) and increased from Dec. 2022 ($447 Mil) to Dec. 2023 ($449 Mil).

Bio-Rad Laboratories Additional Paid-In Capital Historical Data

The historical data trend for Bio-Rad Laboratories's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Additional Paid-In Capital Chart

Bio-Rad Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

410.02

429.38

441.73

447.45

449.08

Bio-Rad Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Additional Paid-In Capital	Get a 7-Day Free Trial															439.46	449.08	462.63	474.73	448.33

Bio-Rad Laboratories Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Bio-Rad Laboratories Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Rad Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

BIO:USA

Address

1000 Alfred Nobel Drive, Hercules, CA, USA, 94547

Website

https://www.bio-rad.com

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.